Many UK CBD brands have been misled on how to prepare for the looming novel foods deadline meaning there is less than one month for some to pull together potentially impossible amounts of data, an industry expert has warned.
The study marks the first time humans were included in a peer-reviewed investigation of commercially available CBD product pharmacokinetics. Previous CBD studies have generally based their claims on animal model studies.
Guelph-based Nutrasource Pharmaceutical and Nutraceutical Services has received approval for an official Institution-Wide Cannabis Research License, paving the way for human research on cannabis and cannabis-derived compounds.
The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act has been re-introduced in the US House of Representatives with the aim of making hemp and hemp-derived CBD a dietary ingredient in dietary supplements.
The White House Office of Management and Budget pulled six FDA guidances and rules from its review, including the proposal "Cannabidiol Enforcement Policy; Draft Guidance for Industry" — handing the CBD industry yet another setback.
It may be a new year, but immunity is still the name of the game. From functional beverages to powders, we’re seeing immunity run the gamut in January launches. The month also welcomed some unexpected formats and even something for the fur babies.